Apyx Medical Corporation (APYX)
Company Description
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide.
The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures.
The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market.
It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019.
Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
| Country | United States |
| IPO Date | Jan 1, 1987 |
| Industry | Health Care Equipment & Supplies |
| Sector | Health Care |
| Employees | 272 |
| CEO | Charles Goodwin |
Contact Details
Address: 5115 Ulmerton Rd Clearwater, Florida 33760-4004 United States | |
| Phone | 727 384 2323 |
| Website | apyxmedical.com |
Stock Details
| Ticker Symbol | APYX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | US Dollars |
| CIK Code | 0000719135 |
Key Executives
| Name | Position |
|---|---|
| Charles D. Goodwin II | President, Chief Executive Officer and Director |
| Tara H. Semb | Chief Financial Officer, Treasurer and Secretary |
| Moshe Citronowicz | Senior Vice President |
| Todd Hornsby | Executive Vice President |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 19, 2022 | 4 | Statement of changes in beneficial ownership of securities |
| May 12, 2022 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
| May 12, 2022 | 8-K | Current report |
| Apr 4, 2022 | 8-K | Current report |
| Mar 22, 2022 | 4 | Statement of changes in beneficial ownership of securities |
| Mar 21, 2022 | 8-K/A | Current report |
| Mar 17, 2022 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] |
| Mar 17, 2022 | 8-K | Current report |
| Mar 14, 2022 | 8-K | Current report |
| Feb 14, 2022 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals |
| View All SEC Filings | ||